Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor — Neutral
NUVL PRNewsWire — April 29, 2025CAMBRIDGE, Mass. , April 29, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the publication of a manuscript in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research, which supports the rational molecular design of zidesamtinib, its novel and selective ROS1 inhibitor.

Social media behemoth Meta unveiled its first standalone AI assistant app on Tuesday as it tries to take on ChatGPT by giving users a direct path to its generative artificial intelligence models.

Royal Caribbean Profit, Outlook Boosted by Higher Prices, Lower Costs — Positive
RCL Investopedia — April 29, 2025Royal Caribbean Group (RCL) reported quarterly profit exceeded forecasts and it boosted its outlook as it benefited from higher prices and lower costs.

Is NBIS Stock Worth Investing After a 24% Drop in the Past 3 Months? — Neutral
NBIS Zacks Investment Research — April 29, 2025Nebius benefits from expanding infrastructure offerings, but intense competition from tech behemoths and macroeconomic challenges remain concerns.

Amazon says it won't show tariff impact on prices. That's actually a good sign. — Positive
AMZN Market Watch — April 29, 2025Amazon probably won't be hiking prices too much if it's declining to show how much tariffs are impacting costs.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Affirm Holdings, Inc. - AFRM — Neutral
AFRM GlobeNewsWire — April 29, 2025NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Hims & Hers stock pops on Novo Nordisk partnership — Positive
HIMS NVO Proactive Investors — April 29, 2025Hims & Hers (NYSE:HIMS) shares surged after it announced a partnership with Novo Nordisk that will allow it to offer the drugmaker's weight loss product Wegovy through its telehealth platform. Investors welcomed the collaboration, which positions Hims & Hers to participate directly in the fast-growing market for GLP-1 weight-loss drugs.

Uber's strong network effects and exclusive Waymo partnership position it as a key player in the autonomous vehicle market, enhancing its long-term growth prospects. Uber's core business segments, Mobility and Delivery, are performing well, showing significant year-over-year growth and strong operating leverage. At a 23x forward P/E, Uber is undervalued relative to its growth prospects, with a price target of $130, indicating a 70% upside.

Xylem Inc. (NYSE:XYL ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Keith Buettner - Vice President, Investor Relations & Financial Planning & Analysis Matthew Pine - Chief Executive Officer Bill Grogan - Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Mike Halloran - Baird Scott Davis - Melius Research Nathan Jones - Stifel Saree Boroditsky - Jefferies Bryan Blair - Oppenheimer Joe Giordano - TD Cowen Operator Good day, and welcome to Xylem's First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

JNPR Set to Report Q1 Results: What's in the Offing for the Stock? — Positive
JNPR Zacks Investment Research — April 29, 2025Juniper is expected to report top-line growth backed by healthy demand in the Cloud and Enterprise segments.

Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales — Positive
PFE Zacks Investment Research — April 29, 2025PFE beats first-quarter estimates for earnings but misses the same for sales. It maintains 2025 guidance.

Oil companies that Trump wants to ‘drill, baby, drill' have taken a beating since he took office — Negative
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP CNBC — April 29, 2025President Donald Trump's wants to "drill, baby, drill" but his first 100 days in office have been rough for oilfield service firms. Baker Hughes and SLB see investment in drilling slowing this year as oil prices fall because of growing supply and concern over a recessionary slowdown.

S&P Global Inc. (SPGI) Q1 2025 Earnings Call Transcript — Neutral
SPGI Seeking Alpha — April 29, 2025S&P Global Inc. (NYSE:SPGI ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Mark Grant - Senior Vice President of Investor Relations Martina Cheung - President and Chief Executive Officer Eric Aboaf - Chief Financial Officer Conference Call Participants Toni Kaplan - Morgan Stanley Faiza Alwy - Deutsche Bank Surinder Thind - Jefferies Ashish Sabadra - RBC Capital Markets Andrew Steinerman - JPMorgan Scott Wurtzel - Wolfe Research Alex Kramm - UBS Manav Patnaik - Barclays George Tong - Goldman Sachs Tom Ross - William Blair Craig Huber - Huber Research Partners Owen Lau - …

Levi & Korsinsky Reminds AppLovin Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - APP — Neutral
APP Accesswire — April 29, 2025NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your AppLovin Corporation (NASDAQ:APP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applovin-corporation-lawsuit-submission-form?prid=146027&wire=1 or contact Joseph E. Levi, Esq.

PPTA LAWSUIT ALERT: Levi & Korsinsky Notifies Perpetua Resources Corp. Investors of a Class Action Lawsuit and Upcoming Deadline — Neutral
PPTA Accesswire — April 29, 2025NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=146023&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds TFI International Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2025 - TFII — Neutral
TFII Accesswire — April 29, 2025NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your TFI International Inc. (NYSE:TFII) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tfi-international-inc-lawsuit-submission-form?prid=146026&wire=1 or contact Joseph E. Levi, Esq.

Regeneron Pharmaceuticals, Inc. (REGN) Q1 2025 Earnings Call Transcript — Neutral
REGN Seeking Alpha — April 29, 2025Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Ryan Crowe - SVP, IR Leonard Schleifer - Board Co-Chair, Co-Founder, President and CEO George Yancopoulos - Board Co-Chair, Co-Founder, President and Chief Scientific Officer Marion McCourt - EVP, Commercial Chris Fenimore - EVP and CFO Conference Call Participants Tyler Van Buren - TD Cowen Alexandria Hammond - Wolfe Research Chris Schott - JPMorgan Terence Flynn - Morgan Stanley Akash Tewari - Jefferies Carter Gould - Cantor William Pickering - Bernstein Evan Seigerman - BMO Capital Markets Salveen Richter - Goldman Sachs …

Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI — Neutral
TMCI Accesswire — April 29, 2025NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=146022&wire=1 or contact Joseph E. Levi, Esq.

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of the Hertz Corporation Data Breach — Neutral
HTZ Accesswire — April 29, 2025NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / The Hertz Corporation recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted to Hertz.

Levi & Korsinsky, LLP Investigates eBay Privacy Violation — Neutral
EBAY Accesswire — April 29, 2025NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky, LLP is investigating potential claims on behalf of California residents, who are account holders with eBay and visited eBay's website at https://www.ebay.com. Levi &Korsinsky, LLP's investigation indicatesthat legally protected data may have been unlawfully intercepted during visits to eBay's website, particularly affectingusers who are California residents and areaccount holders with eBay.
